Literature DB >> 10226737

Interleukin-5 and the regulation of eosinophil production.

G J Roboz1, S Rafii.   

Abstract

Eosinophils play important roles in adaptive immune responses, inflammatory processes, and disease states. Recently, considerable research has been devoted to better defining the normal and abnormal biology of these cells, specifically their origin and mechanisms of stimulation, chemotaxis, regulation, and activation. Interleukin-5 has been identified as a major regulator of eosinophil development and function. This review highlights current literature on interleukin-5 and eosinophil production. Areas covered include molecular signaling, physiologic sources of interleukin-5, and interactions between interleukin-5, eosinophils, and the bone marrow microenvironment. Clinical correlates are also presented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226737     DOI: 10.1097/00062752-199905000-00007

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  12 in total

1.  In vivo imaging of tissue eosinophilia and eosinopoietic responses to schistosome worms and eggs.

Authors:  Stephen J Davies; Steven J Smith; K C Lim; Hongbing Zhang; Anthony F Purchio; James H McKerrow; David B West
Journal:  Int J Parasitol       Date:  2005-07       Impact factor: 3.981

Review 2.  Innate and adaptive immunity to the nematode Strongyloides stercoralis in a mouse model.

Authors:  Sandra Bonne-Année; Jessica A Hess; David Abraham
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

3.  More than 13 years of hypereosinophila associated with clonal CD3-CD4+ lymphocytosis of TH2/TH0 type.

Authors:  Koichi Sugimoto; Kenji Tamayose; Makoto Sasaki; Takashi Danbara; Yosuke Aikawa; Hideoki Ogawa; Naotake Sato; Eiji Tashiro; Kazuo Oshimi
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

4.  Wells' syndrome associated with ulcerative colitis: a case report and literature review.

Authors:  Sonali S Sakaria; Anupama Ravi; Robert Swerlick; Shanthi Sitaraman
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

5.  Update on strongyloidiasis in the immunocompromised host.

Authors:  Luis A Marcos; Angélica Terashima; Marco Canales; Eduardo Gotuzzo
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

6.  IL-33-induced alterations in murine intestinal function and cytokine responses are MyD88, STAT6, and IL-13 dependent.

Authors:  Zhonghan Yang; Rex Sun; Viktoriya Grinchuk; Joan Antoni Fernández-Blanco; Joan Antoni Fernandez Blanco; Luigi Notari; Jennifer A Bohl; Leon P McLean; Thirumalai R Ramalingam; Thomas A Wynn; Joseph F Urban; Stefanie N Vogel; Terez Shea-Donohue; Aiping Zhao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-20       Impact factor: 4.052

7.  IL-33 promotes eosinophilia in vivo and antagonizes IL-5-dependent eosinophil hematopoiesis ex vivo.

Authors:  Kimberly D Dyer; Caroline M Percopo; Helene F Rosenberg
Journal:  Immunol Lett       Date:  2012-12-11       Impact factor: 3.685

8.  Identification of a novel antigen-presenting cell population modulating antiinfluenza type 2 immunity.

Authors:  Jae-Kwang Yoo; Carole L Galligan; Carl Virtanen; Eleanor N Fish
Journal:  J Exp Med       Date:  2010-06-14       Impact factor: 14.307

9.  GATA transcription factors regulate the expression of the human eosinophil-derived neurotoxin (RNase 2) gene.

Authors:  Zhijun Qiu; Kimberly D Dyer; Zhihui Xie; Madeleine Rådinger; Helene F Rosenberg
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

10.  Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E.

Authors:  Colin M Fitzsimmons; Sarah Joseph; Frances M Jones; Claus M Reimert; Karl F Hoffmann; Francis Kazibwe; Gachuhi Kimani; Joseph K Mwatha; John H Ouma; Edridah M Tukahebwa; Henry C Kariuki; Birgitte J Vennervald; Narcis B Kabatereine; David W Dunne
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.